Answers are grounded in this paper and cite their sources.
Study observed broad-spectrum bioactivities in novel hybrids, suggesting potential for multi-target therapies.
Numerous human diseases involving diabetes, Alzheimer’s disease, and inflammation have risks to human health and relation linking them via various causative factors and entanglements. Molecular hybridization was revealed as an enormous tool recently applied for the design of multitargeted drugs providing potent hybrid products. The study aimed for the synthesis of novel pyrazole–naphthalene–heterocycle hybrid and related functionalized analogues as possible multi-targeted bioactive agents. New pyrazole–naphthalene–thiazole and the corresponding pyrimidine analogue hybrids and those possessing aminophenylenone moiety were synthesized through efficient molecular hybridization strategies. The in vitro antioxidant, anti-diabetic, anti-Alzheimer, anti-arthritic, and anti-inflammatory activities was performed. Molecular docking was simulated to rationalize the observed bioactivities. Density Function Theory (DFT) study was performed to understand the electronic properties and reactivity. Drug likeness and pharmacokinetic analysis (via ADME) were also conducted. Synthesis of the targeted structures and structural elucidation was successfully achieved. Compound 5a exhibited the most potent and broad-spectrum profile, showing high free-radical scavenging capacity (TAC: 80.08 mg GAE/g), multi-enzyme inhibitory effects against α-amylase, α-glucosidase, and aldose reductase, and strong COX-1, COX-2, and 5-LOX inhibition. Interestingly, compound 4b demonstrated superior acetylcholinesterase inhibition (78.26%, IC50 = 6.71 µg/mL), indicating selective anti-Alzheimer potential. SAR analysis highlighted the role of π-conjugated aromatic systems, electron-donating substituents, and balanced lipophilicity in multi-target activity. Molecular docking rationalized the afforded bioactivities, revealing strong binding affinities and interactions within the active sites of the target supporting the experimental results. DFT explained comprehensively the electronic properties and reactivity of the enone product 5a in addition to comprehending such molecule’s stability. Drug likeness and pharmacokinetic analysis of compounds 4b and 5a predicted the physicochemical characteristics and affinities. The study findings suggest that structurally modified pyrazole-naphthalene-arylamino hybrid 5a incorporating enone linker, in particular, is a promising lead scaffold for further optimization toward multi-target therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Alshabani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: